For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Viacyte, Inc.

Calculating rank

USPTO Granted Patents = 110

% Expired Patents = 5.5

CIPO Patents = 13

EPO Patents = 35

Trademarks = 3

Forward Citations = 1,872

Loading Chart...

Loading Chart...

45 inventors (with patents filed for the assignee):

Chad Green (42 out of 42 patents)

Kevin Allen D'Amour (40 out of 47 patents)

Laura A Martinson (38 out of 42 patents)

4. Emmanuel Edward Baetge (38 out of 46 patents)

5. Alan D Agulnick (35 out of 39 patents)

6. Michael J Scott (24 out of 45 patents)

7. Thomas C Schulz (22 out of 23 patents)

8. Evert Kroon (20 out of 22 patents)

9. Allan J Robins (19 out of 23 patents)

10. Vincent So (18 out of 21 patents)

11. Olivia Kelly (13 out of 14 patents)

12. Susan Eliazer (11 out of 12 patents)

13. Anne Bang (10 out of 11 patents)

14. Erik D Olson (8 out of 19 patents)

15. Giacomo Strollo (7 out of 12 patents)

Core Competencies:

Universal Donor Cells

Cell Encapsulation Device

Pluripotent Stem Cells

Pancreatic Endoderm Cells

Endocrine Cells

Human Serum Media

PDX1-positive Cells

Cryopreservation

Hormone Production

Implantable Devices

Cell Delivery Methods

3D Cell Assembly

110 patents: Sort by Forward Citations

1. 12576142 - UNIVERSAL DONOR CELLS AND RELATED METHODS (2026-03-17),

2. 12383670 - Instruments and methods for loading cells into implantable devices (2025-08-12),

3. 12310830 - Biocompatible membrane composite (2025-05-27),

4. 12296125 - 3-dimensional large capacity cell encapsulation device assembly (2025-05-13),

5. 12234477 - Scalable primate pluripotent stem cell aggregate suspension culture (2025-02-25),

6. 12173323 - Methods of using PDX1-positive pancreatic endoderm cells and endocrine precursor cells (2024-12-24),

7. 12144908 - PDX1 pancreatic endoderm cells in cell delivery devices and methods thereof (2024-11-19),

8. 11925488 - Tools and instruments for use with implantable encapsulation devices (2024-03-12),

9. 11920154 - Methods and compositions for feeder-free pluripotent stem cell media containing human serum (2024-03-05),

10. 11905530 - Cell encapsulation device comprising a pancreatic progenitor cell population (2024-02-20),

11. 11904001 - Universal donor cells and related methods (2024-02-20),

12. 11896622 - Methods of producing pancreatic hormones (2024-02-13),

13. 11746323 - PDX1 positive foregut endoderm cells and methods of production (2023-09-05),

14. 11667889 - Methods of making human primitive ectoderm cells (2023-06-06),

15. 11660377 - Cryopreserved in vitro cell culture of human pancreatic progenitor cells (2023-05-30),

Company Overview

Viacyte, Inc., based in San Diego, CA, specializes in innovative cell encapsulation technologies aimed at addressing diabetes through regenerative medicine. The company focuses on developing universal donor cells and advanced cell encapsulation devices that utilize pluripotent stem cells to create pancreatic endoderm and endocrine cells. Their research emphasizes the use of human serum media and PDX1-positive cells, alongside cryopreservation techniques, to enhance the viability and functionality of cell therapies for diabetes management.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

110 Patents

#56 in San Diego, CA

#791 in California

#3,480 in US

#7,166 in the World

San Diego, CA, United States of America

Viacyte, Inc.

Forward Citations = 1,872

45 inventors:

Chad Green (42 out of 42 patents)

Kevin Allen D'Amour (40 out of 47 patents)

Laura A Martinson (38 out of 42 patents)

4. Emmanuel Edward Baetge (38 out of 46 patents)

5. Alan D Agulnick (35 out of 39 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Viacyte, Inc.. Retrieved from https://idiyas.com/company/viacyte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…